StockData
Evaxion A/S logo

Evaxion A/S (EVAX) stock

EVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 2/30
$2.54−0.24 (-8.63%)

Close on Nov 18, 2026Market cap $21.18MP/E –Yield –

Evaxion A/S shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2025 it was 320M, up 497.3% from the year before. The highest annual figure on record is 320M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025320M+497.3%
FY2024Dec 31, 202454M+96.2%
FY2023Dec 31, 202327M+15.6%
FY2022Dec 31, 202224M+21.3%
FY2021Dec 31, 202119M+26.3%
FY2020Dec 31, 202015M+11.1%
FY2019Dec 31, 201914M+7.6%
FY2018Dec 31, 201813M–

More Evaxion A/S figures

See a number that looks wrong?